Factors associated with extremely poor visual outcomes in patients with central retinal vein occlusion

• Published in: Scientific reports Vol. 10; no. 1; p. 19667
• Main Authors: Nagasato, Daisuke, Muraoka, Yuki, Osaka, Rie, Iida-Miwa, Yuko, Mitamura, Yoshinori, Tabuchi, Hitoshi, Kadomoto, Shin, Murakami, Tomoaki, Ooto, Sotaro, Suzuma, Kiyoshi, Tsujikawa, Akitaka
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 12-11-2020; Nature Publishing Group
• Subjects: 692/308; 692/699; Acuity; Aged; Aged, 80 and over; Carotid arteries; Carotid artery; Comorbidity; Diabetes; Diabetes mellitus; Diabetic retinopathy; Edema; Humanities and Social Sciences; Humans; Middle Aged; multidisciplinary; Occlusion; Patients; Prognosis; Retina; Retinal Vein Occlusion - complications; Retinopathy; Risk factors; Science; Science (multidisciplinary); Treatment Outcome; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Vision Disorders - etiology; Visual Acuity
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-76840-6

Here, we examined prognostic factors for extremely poor visual outcomes in patients with central retinal vein occlusion (CRVO) in actual practices. We included 150 consecutive eyes with treatment-naïve acute CRVO from four different facilities and observed them for over 24 months. Macular edema (ME) was treated with one or three monthly anti-vascular endothelial growth factor injections (1 or 3 + pro re nata). According to the final Snellen visual acuity (VA), we divided the patients into very poor VA (< 20/200) and control (≥ 20/200) groups and examined risk factors for poor final visual outcomes. The baseline Snellen VA was hand motion to 20/13. The mean number of anti-VEGF injections for ME was 5.3 ± 3.7 during the follow-up period. In total, 49 (32.7%) patients exhibited a very poor final VA; this group comprised significantly older patients with a significantly poorer baseline VA (
P
 < 0.01 for both) than the control group. Comorbid internal carotid artery disease and diabetic retinopathy were significantly associated with a poor final VA. In actual clinical practice, visual outcomes may be extremely poor despite ME treatment in certain patients with CRVO, with advanced age, poor baseline VA, and comorbid internal carotid artery disease and diabetic retinopathy being significant risk factors.